BioSpace News Archive

Business

FDA Issues Emergency Use Authorization For Astrazeneca’s Evusheld™ (Tixagevimab Co-packaged With Cilgavimab), The First Antibody Therapy Authorized In The U.S. For Pre-exposure Prophylaxis Of COVID-19

Brand Institute is proud to announce its successful partnership with AstraZeneca in developing the brand name EVUSHELD™ and assisting with the development of the nonproprietary names tixagevimab and cilgavimab, together denoting the first long-acting antibody combination authorized for emergency use by the U.S. Food and Drug Administration (FDA) for pre-exposure prevention of COVID-19.

December 10, 2021
·
2 min read
Dental Parallelometers Market: Increase in number of dental procedures to drive the market

The parallelometer is an instrument in the dental laboratory that is used to carry out prosthesis design, model surveying, and attachments assembly.

December 10, 2021
·
5 min read
Medical Gel Warmer Device Market: Increase in number of ultrasound & surgical procedures to drive the market

Gel warmer devices are widely utilized in the medical sector. They are deployed by private practitioners along with hospitals and medical clinics worldwide.

December 10, 2021
·
5 min read